← All trials
NCT00568074
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 16, 2003
- Primary completion
- Sep 2, 2004
- Completion date
- Sep 2, 2004
- First posted
- —
- Last posted
- —
- Enrollment
- 131
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Novo NordiskLead sponsor
- Novo NordiskStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.